Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2023 Q1- Text added to 2023 Q2
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
8th grade Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
8th grade Avg
|
New words:
Alkem, Amgen, Ascend, Auson, began, Constitution, constitutionality, DCH, effectuation, equal, forty, FPP, guidance, Hikma, Human, Indoco, IRA, mandatory, par, predominantly, published, repositioning, RP, satisfied, scheme, shown, slightly, TECVAYLI, unfiled, upcoming, Valadez, waste, Westward
Removed:
advance, agreeing, antiretroviral, awarded, Biosense, Boston, broader, broadly, BWI, cART, Center, channel, confirmed, contemplated, Controlled, copayment, Crohn, Density, disruption, Eastern, foresee, grand, half, Hampshire, incur, indirect, ingredient, Innovative, Japan, lapping, led, liquidity, Manufacturer, Mapping, Middle, Oklahoma, OLYSIO, Pacific, palmitate, penalty, persistence, pertaining, petitioned, profile, progression, Psoriatic, purported, rebate, spinal, Squibb, sterilization, subpoena, terminate, Tobacco, Ulcerative, Ultrasound, vast, volume, Webster
Valuein 2023 Q1 filing- Value in 2023 Q2 filing
Original filings
Filing view